Denali Therapeutics (DNLI) EBITDA Margin Growth (1y) (2019 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 4.81 Mn |
| Jun 30, 2023 | 18,051.00 |
| Mar 31, 2023 | -12,918.00 |
| Dec 31, 2022 | -31,989.00 |
| Sep 30, 2022 | -5.43 Mn |
| Jun 30, 2022 | 28,772.00 |
| Mar 31, 2022 | 700.26 Mn |
| Dec 31, 2021 | -69,444.00 |
| Sep 30, 2021 | 117.38 Mn |
| Jun 30, 2021 | 60,427.00 |
| Mar 31, 2021 | -689.46 Mn |
| Dec 31, 2020 | 131,347.00 |
| Sep 30, 2020 | -112.68 Mn |
| Jun 30, 2020 | 5.74 Mn |
| Mar 31, 2020 | -10.73 Mn |
| Dec 31, 2019 | -129,859.00 |
| Sep 30, 2019 | -4.56 Mn |
| Jun 30, 2019 | -5.50 Mn |
| Mar 31, 2019 | 293,334.00 |